Table 4.
Use of support to quit: observations within each demographic group and GEE results (weighted; controlling for wave and demographics).
| Used any pharmacotherapy | Used NRT | Used prescription medication | Behavioural support (Quitline, Internet or clinic) | Pharmacotherapy and/or behavioural support | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Adjusted OR (95% CI) | Adjusted OR (95% CI) | Adjusted OR (95% CI) | Adjusted OR (95% CI) | Adjusted OR (95% CI) | ||||||
| Age | ||||||||||
| 18-24 | 26.1% | Ref | 24.0% | Ref | 2.6% | Ref | 10.2% | Ref | 32.3% | Ref |
| 25-39 | 37.4% | 1.34 (0.95-1.89) | 31.5% | 1.24 (0.87-1.78) | 6.8% | 1.76 (0.72-4.31) | 12.4% | 1.07 (0.66-1.72) | 43.8% | 1.33 (0.96-1.83) |
| 40-54 | 44.5% | 1.78 (1.26-2.53) | 35.4% | 1.45 (1.01-2.08) | 9.2% | 2.24 (0.91-5.51) | 11.6% | 0.94 (0.58-1.52) | 49.9% | 1.60 (1.16-2.22) |
| 55+ | 41.2% | 1.50 (1.03-2.20) | 28.8% | 1.13 (0.76-1.68) | 12.4% | 2.71 (1.07-6.85) | 9.9% | 0.82 (0.48-1.38) | 46.4% | 1.36 (0.96-1.94) |
| Gender | ||||||||||
| Female | 41.6% | Ref | 32.8% | Ref | 9.9% | Ref | 12.9% | Ref | 47.9% | Ref |
| Male | 37.0% | 0.79 (0.65-0.96) | 30.6% | 0.87 (0.71-1.07) | 6.7% | 0.70 (0.50-0.96) | 9.8% | 0.75 (0.58-0.97) | 42.3% | 0.76 (0.63-0.92) |
| SES | ||||||||||
| Low | 39.6% | Ref | 29.4% | Ref | 10.3% | Ref | 11.2% | Ref | 44.8% | Ref |
| Moderate | 39.5% | 1.11 (0.89-1.38) | 32.8% | 1.23 (0.98-1.55) | 7.3% | 0.81 (0.57-1.15) | 10.4% | 0.92 (0.68-1.25) | 45.1% | 1.14 (0.93-1.41) |
| High | 36.7% | 0.98 (0.74-1.29) | 28.9% | 1.07 (0.79 -1.43) | 8.0% | 0.75 (0.45-1.25) | 14.8% | 1.38 (0.95-2.00) | 44.3% | 1.10 (0.84-1.43) |
| Region | ||||||||||
| Metro | 40.2% | Ref | 32.4% | Ref | 8.3% | Ref | 12.6% | Ref | 46.3% | Ref |
| Regional | 37.7% | 0.82 (0.67-1.00) | 29.8% | 0.85 (0.69-1.05) | 8.3% | 0.84 (0.61-1.15) | 9.5% | 0.75 (0.57-0.99) | 43.1% | 0.83 (0.69-1.01) |
| HSI | ||||||||||
| Low | 22.5% | Ref | 19.3% | Ref | 2.5% | Ref | 10.9% | Ref | 29.8% | Ref |
| Moderate | 38.8% | 1.98 (1.51-2.61) | 31.3% | 1.77 (1.33-2.36) | 7.7% | 3.00 (1.45-6.20) | 11.4% | 1.14 (0.73-1.77) | 44.9% | 1.85 (1.41-2.41) |
| High | 47.2% | 2.73 (2.01-3.71) | 36.6% | 2.24 (1.62-3.10) | 12.0% | 4.61 (2.20-9.67) | 11.7% | 1.24 (0.78-1.96) | 54.3% | 2.56 (1.90-3.46) |
| Wave | ||||||||||
| 2002-03 | 31.9% | 0.86 (0.67-1.12) | 27.5% | 0.83 (0.64-1.08) | 4.9% | 0.82 (0.46-1.45) | 8.4% | 0.79 (0.52-1.21) | 37.0% | 0.81 (0.62-1.05) |
| 2003-04 | 35.6% | Ref | 31.5% | Ref | 6.2% | Ref | 10.5% | Ref | 42.4% | Ref |
| 2005-06 | 34.6% | 0.94 (0.73-1.21) | 28.6% | 0.89 (0.68-1.16) | 6.3% | 1.00 (0.60-1.67) | 11.4% | 1.11 (0.74-1.67) | 40.5% | 0.90 (0.70-1.17) |
| 2006-07 | 38.2% | 1.17 (0.89-1.52) | 32.8% | 1.09 (0.82-1.44) | 5.4% | 0.96 (0.55-1.68) | 14.2% | 1.50 (1.03-2.19) | 44.3% | 1.13 (0.86-1.47) |
| 2007-08 | 44.7% | 1.45 (1.11-1.89) | 39.1% | 1.44 (1.09-1.89) | 4.6% | 0.74 (0.42-1.30) | 8.9% | 0.81 (0.52-1.26) | 48.2% | 1.27 (0.97-1.66) |
| 2008-09 | 52.2% | 1.93 (1.47-2.54) | 29.0% | 0.86 (0.63-1.17) | 23.9% | 4.94 (3.11-7.85) | 15.0% | 1.47 (0.98-2.21) | 59.4% | 1.92 (1.46-2.53) |
| Total | 39.2% | 31.3% | 8.3% | 11.3% | 45.0% | |||||
Notes: The sample is of those who made a quit attempt in the previous year. OR = Odds ratio; CI = Confidence interval. For use of any type of pharmacotherapy, NRT, and prescription medication, there were 3065 observations from 1910 individuals. For behaviou\ral support there were 3143 observations from 1945 individuals, and for use of any form of support there were 3094 observations from 1925 individuals. Bold text indicates p<0.05.